Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-106329
Filing Date
2024-10-04
Accepted
2024-10-04 17:22:13
Documents
1
Period of Report
2024-10-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2425653-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2425653-8_4seq1.xml 4 4261
  Complete submission text file 0001104659-24-106329.txt   5832
Mailing Address C/O MACROCURE LTD. 25 HASIVIM STREET PETACH TIKVA L3 4959383
Business Address
Mashiach Nissim (Reporting) CIK: 0001357777 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37990 | Film No.: 241355692

Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)